LNC
WST icon

Lincoln National Corp’s West Pharmaceutical WST Stock Holding History

Lincoln National Corp’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,004
Closed -$793K – 1135
2024
Q1 		$793K Sell
2,004
-110
-5% -$40.7K 0.01% 590
2023
Q4 		$744K Buy
2,114
+310
+17% +$110K 0.01% 541
2023
Q3 		$677K Buy
1,804
+64
+4% +$24.8K 0.01% 503
2023
Q2 		$666K Sell
1,740
-72
-4% -$25.7K 0.01% 505
2023
Q1 		$628K Buy
1,812
+66
+4% +$19.3K 0.01% 511
2022
Q4 		$411K Buy
1,746
+22
+1% +$5.21K 0.01% 595
2022
Q3 		$424K Buy
1,724
+464
+37% +$141K 0.01% 541
2022
Q2 		$381K Buy
1,260
+132
+12% +$43K 0.01% 562
2022
Q1 		$463K Buy
1,128
+254
+29% +$99.4K 0.01% 556
2021
Q4 		$410K Hold
874
– – 0.01% 597
2021
Q3 		$371K Buy
874
+253
+41% +$107K 0.01% 602
2021
Q2 		$223K Buy
+621
New +$205K ﹤0.01% 772

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Lincoln National Corp's WST Position: Q2 2024 in Review

Lincoln National Corp sold out of West Pharmaceutical (WST) in Q2 2024, closing a stake of 2,004 shares — an estimated $793K sold.

Lincoln National Corp first reported a position in WST in Q2 2021 and held it in 12 quarters. The position peaked at $793K in Q1 2024. 776 funds tracked by Wall St. Rank hold WST as of Q2 2024.

  • Lincoln National Corp reported no remaining West Pharmaceutical position as of Q2 2024 after selling out during the quarter.
  • Lincoln National Corp sold 2,004 West Pharmaceutical shares in Q2 2024, an estimated $793K.
  • Lincoln National Corp first reported a position in West Pharmaceutical in Q2 2021 and held it in 12 quarters.
  • Lincoln National Corp's West Pharmaceutical position peaked at $793K in Q1 2024.
  • 776 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2024.

Based on Lincoln National Corp's 13F filing for Q2 2024, filed 25 Jul 2024.